GlassScriptPhysician profile
Alex R Conley
NPI 1568816635
$1,654.87
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Vision Therapy provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.80 · 2020: $288 · 2021: $309 · 2022: $442 · 2023: $112 · 2024: $336 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $346.78 | 2022-2024 | Cequa |
| Biotissue Holdings INC. | $266.50 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $178.26 | 2022-2024 | Xiidra, Miebo |
| Carl Zeiss Meditec, INC. | $159.32 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $138.38 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $134.25 | 2024 | Cirrus Hd-Oct |
| Allergan, INC. | $113.17 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $112.27 | 2021 | |
| Alcon Vision LLC | $76.98 | 2021 | |
| Lensar, INC. | $59.66 | 2020 | |
| Ironshore Pharmaceuticals INC. | $41.35 | 2020 | |
| Sight Sciences, INC. | $27.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.